Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 8/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | GUSB | P08236 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18873374 | 0.80 | MAPT (0.61) | GAAMAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL24595941 | 0.78 | MAOA (0.42) | GAAMAPTMEN1KMT2AXIAP | |
| SCHEMBL17696370 | 0.72 | MAPT (0.57) | GAAMAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL18873414 | 0.72 | XIAP (0.43) | GAAMAPTMEN1KMT2AXIAP | |
| SCHEMBL20369933 | 0.71 | XIAP (0.42) | MAPTMEN1KMT2AXIAPMAOA | |
| SCHEMBL17696369 | 0.70 | MAPT (0.67) | GAAMAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL17933317 | 0.69 | XIAP (0.58) | GAAMAPTMEN1KMT2AXIAP | |
| SCHEMBL17696367 | 0.67 | MAPT (0.57) | GAAMAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL16705684 | 0.66 | XIAP (0.58) | GAAMAPTMEN1KMT2AXIAP | |
| SCHEMBL2170681 | 0.64 | RAB9A (0.53) | MAPTMEN1KMT2ACYP1A2XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370740-B2 | Method for producing ester group-containing compound | DIC CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20220162505-A1 | Polymerizable LC Material and Polymer Film | MERCK PATENT GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| US-20200362245-A1 | POLYMERISABLE LC MEDIUM AND POLYMER FILM WITH FLAT OPTICAL DISPERSION | MERCK PATENT GMBH (DE) | 2020-11-19 | — | — | US | disclosed |
| US-20200199453-A1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| US-10649124-B2 | Composition including compound having mesogenic group, polymer and optically anisotropic body obtained by polymerizing polymerizable composition, and phase difference film | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20190025490-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| WO-2017079867-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370740-B2 | Method for producing ester group-containing compound | COASY, TAF5, TAF9 | GAA 1486/4885MAPT 782/4885MEN1 786/4885 |
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | ZYX, ZW10, DPY30 | GAA 2711/4885MAPT 545/4885MEN1 2026/4885 |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | OCIAD1, RCC1, OCIAD2 | GAA 3881/4885MAPT 323/4885MEN1 2528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.